Over-expression of both PD-L1 (on different tumor cell types and tumor-associated APC) and PD-L2 (primarily on hematologic cancer cells and tumor-associated APC) is also caused by inflammatory stimuli and signaling networks that are frequently active in tumor micro-environments [36, 51]. The gene discussed is PDCD1LG2; the disease is neoplasm.